002099 海翔药业
等待开盘 03-10 09:30:00
资讯
新帖
简况
海翔药业(002099)2月27日股东户数4.59万户，较上期增加24.55%
证券之星 · 03-09 17:11
海翔药业(002099)2月27日股东户数4.59万户，较上期增加24.55%
海翔药业（002099）披露全资子公司通过美国FDA现场检查公告，3月6日股价上涨2.32%
证券之星 · 03-06
海翔药业（002099）披露全资子公司通过美国FDA现场检查公告，3月6日股价上涨2.32%
海翔药业(002099.SZ)子公司川南药业通过美国FDA现场检查
智通财经 · 03-06
海翔药业(002099.SZ)子公司川南药业通过美国FDA现场检查
海翔药业（002099）披露股份回购进展情况公告，3月2日股价下跌1.36%
中金财经 · 03-03
海翔药业（002099）披露股份回购进展情况公告，3月2日股价下跌1.36%
股市必读：海翔药业（002099）2月27日收盘跌8.27%，主力净流入2958.79万元
证券之星 · 03-02
股市必读：海翔药业（002099）2月27日收盘跌8.27%，主力净流入2958.79万元
2月27日海翔药业（002099）龙虎榜数据：机构净卖出8278.85万元，北向资金净卖出2705.9万元
证券之星 · 02-27
2月27日海翔药业（002099）龙虎榜数据：机构净卖出8278.85万元，北向资金净卖出2705.9万元
海翔药业(002099)2月13日股东户数3.68万户，较上期增加20.78%
证券之星 · 02-25
海翔药业(002099)2月13日股东户数3.68万户，较上期增加20.78%
海翔药业：当前染料行业景气度上行
证券之星 · 02-25
海翔药业：当前染料行业景气度上行
大面积涨停！603000，1分钟封板！超23万手封死
中国基金报 · 02-10
大面积涨停！603000，1分钟封板！超23万手封死
异动快报：海翔药业（002099）2月10日10点11分触及涨停板
证券之星 · 02-10
异动快报：海翔药业（002099）2月10日10点11分触及涨停板
异动快报：海翔药业（002099）2月9日9点32分触及涨停板
证券之星 · 02-09
异动快报：海翔药业（002099）2月9日9点32分触及涨停板
异动快报：海翔药业（002099）2月6日11点4分触及涨停板
证券之星 · 02-06
异动快报：海翔药业（002099）2月6日11点4分触及涨停板
股市必读：海翔药业(002099)股东户数3.05万户，较上期减少1.46%
证券之星 · 02-04
股市必读：海翔药业(002099)股东户数3.05万户，较上期减少1.46%
海翔药业（002099）披露股份回购进展情况公告，2月2日股价上涨7.58%
证券之星 · 02-02
海翔药业（002099）披露股份回购进展情况公告，2月2日股价上涨7.58%
海翔药业（002099）披露获得地夸磷索钠化学原料药上市申请批准通知书，1月27日股价下跌2.03%
证券之星 · 01-27
海翔药业（002099）披露获得地夸磷索钠化学原料药上市申请批准通知书，1月27日股价下跌2.03%
海翔药业：截止1月20日公司股东人数为30934人
证券之星 · 01-21
海翔药业：截止1月20日公司股东人数为30934人
股市必读：海翔药业（002099）1月19日董秘有最新回复
证券之星 · 01-20
股市必读：海翔药业（002099）1月19日董秘有最新回复
海翔药业：截至1月9日股东人数为31210人
证券之星 · 01-14
海翔药业：截至1月9日股东人数为31210人
海翔药业：参投基金持有天兵科技1.352%股权
证券之星 · 01-14
海翔药业：参投基金持有天兵科技1.352%股权
海翔药业：公司未持有星河动力股票
证券之星 · 01-13
海翔药业：公司未持有星河动力股票
加载更多
公司概况
公司名称：
浙江海翔药业股份有限公司
所属行业：
医药制造业
上市日期：
2006-12-26
主营业务：
浙江海翔药业股份有限公司的主营业务是医药及染料全产业链业务。公司的主要产品是原料药及医药中间体、合同定制业务、制剂、染料及染颜料中间体。公司已承担完成国家级项目13项，省级项目35项，拥有国内发明专利61项、PCT专利4项，荣获浙江省级科技奖项11项。
发行价格：
11.56
{"stockData":{"symbol":"002099","market":"SZ","secType":"STK","nameCN":"海翔药业","latestPrice":7.6,"timestamp":1773105900000,"preClose":7.53,"halted":0,"volume":331500,"delay":0,"changeRate":0.0093,"floatShares":1616000000,"shares":1619000000,"eps":-0.207,"marketStatus":"等待开盘","change":0.07,"latestTime":"03-10 09:30:00","open":7.6,"high":7.6,"low":7.6,"amount":2519400,"amplitude":0,"askPrice":7.61,"askSize":20,"bidPrice":7.6,"bidSize":83,"shortable":0,"etf":0,"ttmEps":-0.207,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773106200000},"marketStatusCode":7,"adr":0,"adjPreClose":7.53,"symbolType":"stock","openAndCloseTimeList":[[1773106200000,1773113400000],[1773118800000,1773126000000]],"highLimit":8.28,"lowLimit":6.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1618715253,"isCdr":false,"pbRate":2.38,"roa":"--","roe":"0.14%","epsLYR":-0.21,"committee":0.048404,"marketValue":12302000000,"turnoverRate":0.0002,"status":0,"floatMarketCap":12279000000},"requestUrl":"/m/hq/s/002099","defaultTab":"news","newsList":[{"id":"2618416886","title":"海翔药业(002099)2月27日股东户数4.59万户，较上期增加24.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618416886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618416886?lang=zh_cn&edition=full","pubTime":"2026-03-09 17:11","pubTimestamp":1773047500,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海翔药业披露，截至2026年2月27日公司股东户数为4.59万户，较2月13日增加9039.0户，增幅为24.55%。在化学制药行业个股中，海翔药业股东户数高于行业平均水平，截至2月27日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年2月13日至2026年2月27日，海翔药业区间涨幅为8.29%，在此期间股东户数增加9039.0户，增幅为24.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900022870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0192","BK0028","BK0188","BK0239","002099"],"gpt_icon":0},{"id":"2617182636","title":"海翔药业（002099）披露全资子公司通过美国FDA现场检查公告，3月6日股价上涨2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617182636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617182636?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:53","pubTimestamp":1772808789,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，海翔药业报收于7.5元，较前一交易日上涨2.32%，最新总市值为121.4亿元。近日，海翔药业发布公告称，其全资子公司浙江海翔川南药业有限公司于2025年10月27日至31日接受美国FDA的cGMP现场检查，近日收到FDA签发的现场检查报告，检查结果为NAI，表明其符合美国药品cGMP要求，顺利通过检查。川南药业为浙江海翔药业全资子公司，此次系连续第5次通过FDA现场检查。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600040676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0192","BK0188","BK0239","BK0077","BK0028","002099"],"gpt_icon":0},{"id":"2617681930","title":"海翔药业(002099.SZ)子公司川南药业通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2617681930","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617681930?lang=zh_cn&edition=full","pubTime":"2026-03-06 18:36","pubTimestamp":1772793365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海翔药业(002099.SZ)公告，公司全资子公司浙江海翔川南药业有限公司(简称“川南药业”)于2025年10月27日至2025年10月31日期间接受了美国食品药品监督管理局(“FDA”)的cGMP(现行药品生产质量管理规范)现场检查。近日，公司收到川南药业转发的美国FDA签发的现场检查报告，该报告表明川南药业符合美国药品cGMP要求，通过了本次现场检查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海翔药业(002099.SZ)子公司川南药业通过美国FDA现场检查","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0028","BK0239","002099","BK0188","BK0192"],"gpt_icon":0},{"id":"2616360278","title":"海翔药业（002099）披露股份回购进展情况公告，3月2日股价下跌1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360278","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616360278?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:05","pubTimestamp":1772496348,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年3月2日收盘，海翔药业报收于7.99元，较前一交易日下跌1.36%，最新总市值为129.34亿元。近日，海翔药业发布《关于股份回购进展情况的公告》。公告显示，公司于2025年4月9日召开董事会，审议通过回购股份方案，拟使用自有或自筹资金通过集中竞价交易方式回购公司股份，用于未来股权激励或员工持股计划。回购进展符合相关法规及既定方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260303/32039712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0077","BK0188","002099","BK0239","BK0192","BK0028"],"gpt_icon":0},{"id":"2616736188","title":"股市必读：海翔药业（002099）2月27日收盘跌8.27%，主力净流入2958.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616736188","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616736188?lang=zh_cn&edition=full","pubTime":"2026-03-02 01:03","pubTimestamp":1772384591,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，海翔药业报收于8.1元，下跌8.27%，换手率9.27%，成交量149.74万手，成交额12.1亿元。来自龙虎榜上榜：海翔药业因日跌幅偏离值达到7%的前5只证券于2月27日登上龙虎榜，为近5个交易日内首次上榜。交易信息汇总股价提醒2月27日海翔药业收盘报8.1元，跌8.27%，当日成交1.5亿元。资金流向2月27日主力资金净流入2958.79万元；游资资金净流入3192.95万元；散户资金净流出6151.74万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","002099","BK0192","BK0077"],"gpt_icon":0},{"id":"2614351258","title":"2月27日海翔药业（002099）龙虎榜数据：机构净卖出8278.85万元，北向资金净卖出2705.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614351258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614351258?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:21","pubTimestamp":1772184077,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年2月27日公布的交易公开信息显示，海翔药业因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年2月27日收盘，海翔药业报收于8.1元，下跌8.27%，换手率9.27%，成交量149.74万手，成交额12.1亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出8278.85万元，北向资金合计净卖出2705.9万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700028860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0192","BK0188","BK0028","BK0239","002099","BK0077"],"gpt_icon":0},{"id":"2614702574","title":"海翔药业(002099)2月13日股东户数3.68万户，较上期增加20.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614702574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614702574?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:18","pubTimestamp":1772011091,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海翔药业披露，截至2026年2月13日公司股东户数为3.68万户，较1月30日增加6335.0户，增幅为20.78%。在化学制药行业个股中，海翔药业股东户数高于行业平均水平，截至2月13日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月13日，海翔药业区间涨幅为18.17%，在此期间股东户数增加6335.0户，增幅为20.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500027612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002099","BK0239","BK0077","BK0028","BK0192"],"gpt_icon":0},{"id":"2614709256","title":"海翔药业：当前染料行业景气度上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2614709256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614709256?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:24","pubTimestamp":1772007862,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的燃料及燃料中间体今年有没有涨价？涨价幅度大概多少呢？谢谢海翔药业回复：您好，当前染料行业景气度上行，公司染料板块会综合考虑主要原材料成本变动情况、市场供需关系以及下游客户情况等多重因素，及时调整销售策略。关于具体产品在特定时间窗口的价格调整细节，属于商业秘密，不便对外披露。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500025131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002099","BK0188","BK0192","BK0077","BK0028"],"gpt_icon":0},{"id":"2610925286","title":"大面积涨停！603000，1分钟封板！超23万手封死","url":"https://stock-news.laohu8.com/highlight/detail?id=2610925286","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610925286?lang=zh_cn&edition=full","pubTime":"2026-02-10 12:15","pubTimestamp":1770696919,"startTime":"0","endTime":"0","summary":"2月10日上午，A股市场震荡调整，截至午间收盘，沪指跌0.02%，深成指跌0.02%，创业板指跌0.14%。消息面上，字节跳动近日发布Seedance2.0，可根据文本或图像创建电影级视频。消息面上，2025年中国创新药License-out总交易规模达到创纪录的1357亿美元。本次接续采购的药品覆盖抗感染、抗肿瘤、降血糖、降血压、降血脂、神经系统、呼吸系统、消化系统等26个治疗领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210121931a491d273&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210121931a491d273&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1303224171.USD","LU0084288322.USD","LU0259732245.USD","LU1023057109.AUD","LU0348805143.USD","LU0531971595.HKD","LU1481107354.HKD","IE00BGV7N243.SGD","LU0791591158.USD","IE00B3M56506.USD","LU1328277881.USD","BK1502","LU0791590937.USD","LU0052750758.USD","LU0588545730.USD","LU0431992006.USD","LU1808992512.USD","LU0588545904.SGD","LU0650527681.SGD","JD","LU0588545490.SGD","LU0128522157.USD","LU0359201612.USD","BK1591","LU0359201885.HKD","SG9999002562.SGD","LU2242644610.SGD","LU0307460666.USD","LU2039709279.SGD","LU0456827905.SGD","LU1282649810.SGD","LU0543330483.HKD","LU0228367735.SGD","LU0828237510.HKD","IE0032431581.USD","LU1720050803.USD","LU0327786744.USD","LU1044874839.SGD","LU0370786039.SGD","89618","BK1161","LU0594300419.USD","LU0345775950.USD","LU0315179316.USD","BK1588","LU1044875133.USD","LU0164865239.USD","300364","LU0708995583.HKD","LU0871576103.HKD","LU1251922891.USD","LU1366334651.USD","LU0868486357.SGD","SG9999001226.SGD","BK1574","LU0228659784.USD","BK1610","LU0320764755.SGD","300251","LU0469268626.HKD","LU0048580855.USD","BK1249","LU1770036033.HKD","BK1142","LU1044876610.USD","LU0348825331.USD","06978","LU0140636845.USD","BK1615","BK1575","LU0211977185.USD","LU0488056044.USD","LU1813983027.USD","LU0456846285.SGD","LU0417516902.SGD","LU0164880469.USD","BK1619","002099","LU0417516738.SGD","LU1794554557.SGD","LU0149721374.USD","LU0029875118.USD","LU1770034418.SGD","LU1719994722.HKD","SG9999002828.SGD","IE00B29SXG58.USD","LU0384037296.USD","LU0293314216.USD","01211","LU0314109678.HKD","LU0359202008.SGD","LU1282651121.HKD","LU0499858602.USD","LU0051755006.USD","LU0231483743.USD","LU0456842615.SGD","LU0345776255.USD","LU0865486749.SGD","LU1282649067.USD","LU0499858438.USD","LU1366334578.USD","LU0163747925.USD","LU0315178854.USD","LU0572944931.SGD","LU1224444064.USD","603000","LU0348735423.USD","LU0320764599.SGD","LU0588546209.SGD","LU0672654166.SGD","LU0039217434.USD","LU1282651048.USD","LU2257852520.SGD","LU1642822792.SGD"],"gpt_icon":0},{"id":"2610696112","title":"异动快报：海翔药业（002099）2月10日10点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2610696112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610696112?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:15","pubTimestamp":1770689721,"startTime":"0","endTime":"0","summary":"证券之星2月10日盘中消息，10点11分海翔药业触及涨停板。其所属行业化学制药目前上涨。该股为染料，创新药，减肥药概念热股，当日染料概念上涨1.49%，创新药概念上涨0.59%，减肥药概念上涨0.46%。2月9日的资金流向数据方面，主力资金净流入738.48万元，占总成交额0.81%，游资资金净流出1224.28万元，占总成交额1.35%，散户资金净流入485.8万元，占总成交额0.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000010482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002099","BK0077","BK0188","BK0028","BK0192","BK0239"],"gpt_icon":0},{"id":"2610501740","title":"异动快报：海翔药业（002099）2月9日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2610501740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610501740?lang=zh_cn&edition=full","pubTime":"2026-02-09 09:35","pubTimestamp":1770600943,"startTime":"0","endTime":"0","summary":"证券之星2月9日盘中消息，9点32分海翔药业触及涨停板。其所属行业化学制药目前上涨。领涨股为诺诚健华。该股为染料，减肥药，新冠病毒防治概念热股，当日染料概念上涨4.14%，减肥药概念上涨0.91%，新冠病毒防治概念上涨0.8%。2月6日的资金流向数据方面，主力资金净流入1.01亿元，占总成交额13.73%，游资资金净流出4981.23万元，占总成交额6.77%，散户资金净流出5127.46万元，占总成交额6.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900002992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","BK0192","BK0028","002099"],"gpt_icon":0},{"id":"2609537733","title":"异动快报：海翔药业（002099）2月6日11点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2609537733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609537733?lang=zh_cn&edition=full","pubTime":"2026-02-06 11:05","pubTimestamp":1770347119,"startTime":"0","endTime":"0","summary":"证券之星2月6日盘中消息，11点4分海翔药业触及涨停板。其所属行业化学制药目前上涨。领涨股为诺诚健华。该股为染料，化学原料药，医药概念热股，当日染料概念上涨3.56%，化学原料药概念上涨1.73%，医药概念上涨1.53%。2月5日的资金流向数据方面，主力资金净流出3379.43万元，占总成交额16.09%，游资资金净流出177.57万元，占总成交额0.85%，散户资金净流入3557.0万元，占总成交额16.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600014262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002099","BK0188","BK0077","BK0239","BK0192"],"gpt_icon":0},{"id":"2608180691","title":"股市必读：海翔药业(002099)股东户数3.05万户，较上期减少1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608180691","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608180691?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:00","pubTimestamp":1770138038,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，海翔药业报收于6.92元，上涨1.62%，换手率4.62%，成交量74.71万手，成交额5.09亿元。来自公司公告汇总：截至2026年1月31日，公司已累计回购股份14,315,300股，占总股本的0.8844%，成交金额达8888.13万元。股本股东变化股东户数变动近日海翔药业披露，截至2026年1月30日公司股东户数为3.05万户，较1月20日减少451.0户，减幅为1.46%。户均持股数量由上期的5.23万股增加至5.31万股，户均持股市值为33.61万元。董秘： 您好，截止1月30日公司股东人数为30483人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400000672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","BK0028","002099","BK0192"],"gpt_icon":0},{"id":"2608862209","title":"海翔药业（002099）披露股份回购进展情况公告，2月2日股价上涨7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608862209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608862209?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:07","pubTimestamp":1770041239,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，海翔药业报收于6.81元，较前一交易日上涨7.58%，最新总市值为110.23亿元。该股当日开盘6.3元，最高6.96元，最低6.25元，成交额达6.88亿元，换手率为6.3%。近日，海翔药业发布《关于股份回购进展情况的公告》。公告显示，公司于2025年4月9日召开董事会，审议通过回购股份方案，拟使用自有/自筹资金以集中竞价方式回购公司股份，用于股权激励或员工持股计划。回购进展符合相关规定及既定方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200038879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0192","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2606178020","title":"海翔药业（002099）披露获得地夸磷索钠化学原料药上市申请批准通知书，1月27日股价下跌2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606178020","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606178020?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:22","pubTimestamp":1769523744,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，海翔药业报收于6.27元，较前一交易日下跌2.03%，最新总市值为101.49亿元。该股当日开盘6.42元，最高6.42元，最低6.18元，成交额达1.36亿元，换手率为1.35%。近日，浙江海翔药业股份有限公司收到国家药品监督管理局核准签发的地夸磷索钠《化学原料药上市申请批准通知书》，批准该原料药注册。地夸磷索钠为P2Y2受体激动剂，用于干眼症治疗。2024年其滴眼液在中国城市公立医院销售额为13,089万元。未来生产销售时间及市场情况存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0239","002099","BK0188","BK0192"],"gpt_icon":0},{"id":"2605217292","title":"海翔药业：截止1月20日公司股东人数为30934人","url":"https://stock-news.laohu8.com/highlight/detail?id=2605217292","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605217292?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:54","pubTimestamp":1768985650,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：截至1月20日公司的股东人数为多少？海翔药业回复：您好，截止1月20日公司股东人数为30934人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100027322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002099","BK0188","BK0077","BK0192","BK0239"],"gpt_icon":0},{"id":"2604305131","title":"股市必读：海翔药业（002099）1月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604305131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604305131?lang=zh_cn&edition=full","pubTime":"2026-01-20 01:58","pubTimestamp":1768845490,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，海翔药业报收于6.54元，上涨0.31%，换手率1.22%，成交量19.67万手，成交额1.28亿元。公司公告汇总关于参投合伙企业投资复宏汉霖的进展公告浙江海翔药业股份有限公司出资1亿元参与设立杭州复宏股权投资合伙企业，专项投资于复宏汉霖的非上市股份。2026年1月19日，公司收到合伙企业通知，复宏汉霖已获中国证监会备案，其部分股东持有的境内未上市股份将转为H股并在香港联交所上市流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000000793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","002099","BK0192","BK0077"],"gpt_icon":0},{"id":"2603660218","title":"海翔药业：截至1月9日股东人数为31210人","url":"https://stock-news.laohu8.com/highlight/detail?id=2603660218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603660218?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:31","pubTimestamp":1768375874,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：截至1月9日公司股东人数为多少？海翔药业回复：您好，截止1月9日公司股东人数为31210人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400020384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0192","BK0188","002099","BK0077","BK0028"],"gpt_icon":0},{"id":"2603660229","title":"海翔药业：参投基金持有天兵科技1.352%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2603660229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603660229?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:27","pubTimestamp":1768375638,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，你好！根据相关AI检索，贵公司通过某投资基金，参投了两家商业航天公司的相关股权。请介绍一下具体情况，穿透股权比例，及后续相关投资安排等。谢谢！海翔药业回复：您好，公司参投的寓鑫基金分别持有天兵科技和爱思达航天的1.352%股权和2.83%股权。根据公开信息，两家公司已启动了IPO辅导。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400020270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002099","BK0188","BK0077","BK0192"],"gpt_icon":0},{"id":"2603657187","title":"海翔药业：公司未持有星河动力股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2603657187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603657187?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:35","pubTimestamp":1768275305,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：网传公司持有星河动力股票是否属实？如有请告知占股比例多少！谢谢海翔药业回复：您好，公司未持有星河动力股票。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300016068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002099","BK0188","BK0077","BK0192","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773105969411,"stockEarnings":[{"period":"1week","weight":-0.0576},{"period":"1month","weight":0.0027},{"period":"3month","weight":0.2029},{"period":"6month","weight":0.1766},{"period":"1year","weight":0.6586},{"period":"ytd","weight":0.2067}],"compareEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.0479},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.2147},{"period":"ytd","weight":0.0322}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海翔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"45857人(较上一季度增加24.55%)","perCapita":"35233股","listingDate":"2006-12-26","address":"浙江省台州市椒江区外沙支路100号","registeredCapital":"161871万元","survey":" 浙江海翔药业股份有限公司的主营业务是医药及染料全产业链业务。公司的主要产品是原料药及医药中间体、合同定制业务、制剂、染料及染颜料中间体。公司已承担完成国家级项目13项，省级项目35项，拥有国内发明专利61项、PCT专利4项，荣获浙江省级科技奖项11项。","listedPrice":11.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海翔药业(002099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海翔药业(002099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海翔药业,002099,海翔药业股票,海翔药业股票老虎,海翔药业股票老虎国际,海翔药业行情,海翔药业股票行情,海翔药业股价,海翔药业股市,海翔药业股票价格,海翔药业股票交易,海翔药业股票购买,海翔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海翔药业(002099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海翔药业(002099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}